Research

New study highlights potential boost to brain stimulation therapy through targeted symptom provocation

This is the first large-scale meta-analysis to examine whether deliberately triggering symptoms immediately before administering rTMS enhances treatment outcomes.

VUMC team finds potential target to slow atherosclerosis

The research findings suggest that regulating the immune response to high cholesterol through the protein CaMK4 could enhance blood vessel repair and slow atherosclerosis progression.

AI researchers develop new technologies for cancer care  

These new technologies showcase how VUMC researchers are using the power of AI to meet a wide range of medical needs.

Andreana Holowatyj named ‘40 Under 40 In Cancer’ winner

The awards initiative identifies and recognizes contributions across the field of cancer by rising stars and emerging leaders under the age of 40.

Molly Knostman, PharmD, MHA, (front) executive director of Inpatient Pharmacy Operations, was honored during the LHS Symposium. Behind her, from left, are Cheryl Gatto, PhD, PMP, Wesley Self, MD, MPH, Sunil Kripalani, MD, MSc, and Matthew Semler, MD, MSCI. (photo by Susan Urmy)

Symposium keynote: Human behavior is the pathway for transforming health

In two panel discussions, VUMC experts described ways to “scale-up and spread” the impact of health care interventions across systems, and the importance of patient-centered learning health system research.

Huda Akil, PhD

Neuroscientist Huda Akil wins Vanderbilt Prize in Biomedical Science

Established by VUMC in 2006, the Vanderbilt Prize in Biomedical Science recognizes scientists of national reputation who have a stellar record of research accomplishments and are known for mentoring others in science.

1 2 3 128